NASDAQ:LQDA

Liquidia Stock Forecast, Price & News

$2.61
-0.07 (-2.61 %)
(As of 06/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.60
$2.70
50-Day Range
$2.52
$3.11
52-Week Range
$2.34
$12.10
Volume575,475 shs
Average Volume975,158 shs
Market Capitalization$135.65 million
P/E RatioN/A
Dividend YieldN/A
Beta0.07
30 days | 90 days | 365 days | Advanced Chart
Receive LQDA News and Ratings via Email

Sign-up to receive the latest news and ratings for Liquidia and its competitors with MarketBeat's FREE daily newsletter.


Liquidia logo

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include LIQ861, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension; and LIQ865, a sustained-release formulation of bupivacaine for the treatment of local post-operative pain. The company also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.50 out of 5 stars

Medical Sector

588th out of 2,097 stocks

Surgical & Medical Instruments Industry

55th out of 174 stocks

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Liquidia (NASDAQ:LQDA) Frequently Asked Questions

Is Liquidia a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Liquidia in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Liquidia stock.
View analyst ratings for Liquidia
or view top-rated stocks.

What stocks does MarketBeat like better than Liquidia?

Wall Street analysts have given Liquidia a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Liquidia wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Liquidia's next earnings date?

Liquidia is scheduled to release its next quarterly earnings announcement on Monday, August 9th 2021.
View our earnings forecast for Liquidia
.

How were Liquidia's earnings last quarter?

Liquidia Co. (NASDAQ:LQDA) announced its quarterly earnings results on Thursday, May, 13th. The company reported ($0.21) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.21). The firm had revenue of $3.08 million for the quarter, compared to the consensus estimate of $0.86 million.
View Liquidia's earnings history
.

How has Liquidia's stock price been impacted by COVID-19 (Coronavirus)?

Liquidia's stock was trading at $3.66 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, LQDA shares have decreased by 28.7% and is now trading at $2.61.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for LQDA?

3 equities research analysts have issued twelve-month target prices for Liquidia's stock. Their forecasts range from $4.00 to $6.00. On average, they expect Liquidia's stock price to reach $5.00 in the next year. This suggests a possible upside of 91.6% from the stock's current price.
View analysts' price targets for Liquidia
or view top-rated stocks among Wall Street analysts.

Who are Liquidia's key executives?

Liquidia's management team includes the following people:
  • Mr. Damian deGoa, CEO & Director (Age 42, Pay $417.31k)
  • Mr. Robert A. Lippe, Chief Operations Officer (Age 56, Pay $547.71k)
  • Dr. Tushar Shah M.D., Sr. VP of Product Devel. & Chief Medical Officer (Age 60, Pay $498.05k)
  • Mr. William R. Kenan Jr., Co-Founder
  • Dr. Ginger Denison, Co-Founder
  • Mr. Michael Kaseta, Chief Financial Officer (Age 45)
  • Jennifer Almond, Director of Investor Relations & Corp. Communications
  • Mr. Russell Schundler, Gen. Counsel & Corp. Sec. (Age 46)
  • Mr. Jason Adair, VP of Corp. Devel. & Strategy (Age 48)
  • Mr. Scott Moomaw, Sr. VP of Commercial (Age 50)

Who are some of Liquidia's key competitors?

What other stocks do shareholders of Liquidia own?

When did Liquidia IPO?

(LQDA) raised $50 million in an initial public offering (IPO) on Thursday, July 26th 2018. The company issued 4,500,000 shares at a price of $10.00-$12.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and Needham & Company and Wedbush PacGrow were co-managers.

What is Liquidia's stock symbol?

Liquidia trades on the NASDAQ under the ticker symbol "LQDA."

Who are Liquidia's major shareholders?

Liquidia's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (4.36%), Geode Capital Management LLC (1.02%), Eversept Partners LP (0.96%), Northern Trust Corp (0.55%), IndexIQ Advisors LLC (0.30%) and Nuveen Asset Management LLC (0.21%). Company insiders that own Liquidia stock include Eshelman Ventures, Llc, Paul B Manning and Timothy Albury.
View institutional ownership trends for Liquidia
.

Which major investors are selling Liquidia stock?

LQDA stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, and Northern Trust Corp.
View insider buying and selling activity for Liquidia
or view top insider-selling stocks.

Which major investors are buying Liquidia stock?

LQDA stock was purchased by a variety of institutional investors in the last quarter, including Eversept Partners LP, IndexIQ Advisors LLC, Geode Capital Management LLC, BlackRock Inc., GSA Capital Partners LLP, Squarepoint Ops LLC, Goldman Sachs Group Inc., and JPMorgan Chase & Co.. Company insiders that have bought Liquidia stock in the last two years include Eshelman Ventures, Llc, and Paul B Manning.
View insider buying and selling activity for Liquidia
or or view top insider-buying stocks.

How do I buy shares of Liquidia?

Shares of LQDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Liquidia's stock price today?

One share of LQDA stock can currently be purchased for approximately $2.61.

How much money does Liquidia make?

Liquidia has a market capitalization of $135.65 million and generates $740,000.00 in revenue each year. The company earns $-59,760,000.00 in net income (profit) each year or ($1.76) on an earnings per share basis.

How many employees does Liquidia have?

Liquidia employs 51 workers across the globe.

What is Liquidia's official website?

The official website for Liquidia is www.liquidia.com.

Where are Liquidia's headquarters?

Liquidia is headquartered at 419 DAVIS DRIVE SUITE 100, MORRISVILLE NC, 27560.

How can I contact Liquidia?

Liquidia's mailing address is 419 DAVIS DRIVE SUITE 100, MORRISVILLE NC, 27560. The company can be reached via phone at (919) 328-4400 or via email at [email protected]


This page was last updated on 6/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.